Smart Nation 2.0: Professor Joseph Sung on artificial intelligence in science
Summary
TLDRProfessor Joseph S, Dean of Lee Kong Chan School of Medicine at NTU, discusses Singapore's $120 million investment in AI for science and medicine. He emphasizes the importance of integrating AI with domain expertise, particularly in clinical medicine, where AI can improve diagnosis and treatment. The funding will support clinical trials and implementation studies to build trust in AI among patients and ensure data security. As AI adoption grows, Singapore aims to stay competitive globally by advancing AI applications in healthcare, enhancing patient outcomes, and leading in technological innovation.
Takeaways
- 💡 Singapore is investing $120 million in AI research, particularly to build a strong research ecosystem and develop a bilingual talent pool proficient in AI and science.
- 🧠 Proficiency in AI and scientific expertise is essential, as AI is increasingly penetrating all aspects of life, especially in areas like clinical medicine.
- 👩⚕️ In medicine, AI can help make more accurate diagnoses and improve patient treatments, but only if healthcare professionals know how to leverage the technology.
- 🔬 The investment will support clinical trials to provide evidence that AI technology can lead to better outcomes for patients.
- 🏥 Beyond clinical trials, the funding will also go toward implementation studies to integrate AI into daily healthcare practices and ensure streamlined services.
- 🔒 Data security is a major concern for patients, who want to ensure their personal information is handled securely when used in AI applications.
- 👨⚕️ Patient trust in AI is crucial, and healthcare providers must use AI responsibly and reassure patients about the safety and accuracy of these technologies.
- 🤖 Patients are generally open to AI, but they show more concern when it comes to major decisions, like surgeries performed by AI-enabled robots.
- 🌍 Singapore is performing well globally in AI in science and healthcare, with strong governmental support and a careful approach to data use.
- 🚀 AI has the potential to benefit various industries, from diagnostics to pharmaceuticals, by advancing technologies like X-rays, CT scans, and robotics.
Q & A
Why is it necessary to be proficient in AI and also an expert in the field of science, according to Professor Joseph?
-AI is penetrating all aspects of life, especially in science and medicine, where it can enhance decision-making, improve diagnosis accuracy, and offer better treatment. Being proficient in AI alongside expertise in science is essential to leverage AI's benefits and avoid being replaced by the technology.
How will the $120 million investment in AI be used in Singapore's smart nation initiative?
-The investment will support building a vibrant research ecosystem and a bilingual talent pool proficient in AI and one domain in science. It will also fund clinical trials and implementation studies to provide evidence that AI can improve patient outcomes and streamline service delivery.
What are the key areas of focus for AI research in medicine according to the professor?
-Key areas include conducting clinical trials to demonstrate AI's effectiveness in improving patient outcomes and performing implementation studies to ensure that AI technologies are seamlessly integrated into clinical practice.
What concerns do patients have about AI in medicine?
-Patients are concerned about the accuracy of AI in recommending the best treatments and about the security of their personal data. They want to ensure that AI-based tools are reliable and that their privacy is protected.
How does Professor Joseph suggest addressing patient concerns about AI in medicine?
-He suggests that clinical trials can demonstrate AI’s accuracy in treatment recommendations, while proper data security measures and transparency in AI usage can alleviate concerns about privacy and trust.
How receptive are patients to the use of AI in medical practice?
-According to Professor Joseph, patients are generally receptive, especially when their doctors and nurses trust the AI tools. However, major decisions, like surgeries performed by AI-driven robots, can still provoke concerns among patients.
What impact will AI adoption have on Singapore in the global competition for science and healthcare innovation?
-AI adoption will help Singapore stay competitive in areas like drug development, vaccines, diagnostics, and medical devices. By investing in AI, Singapore aims to stay at the forefront of healthcare and science innovation globally.
How is Singapore positioned globally in AI for science and medicine?
-Singapore is ahead of many other countries, with a careful use of data and significant government investment in AI research. This positions the country to lead advancements in AI in the healthcare and science sectors.
How will AI impact the broader healthcare and science industries?
-AI can benefit industries involved in diagnostics, pharmaceuticals, and medical devices by improving the accuracy and capabilities of tools like x-rays, CT scans, and robotic surgeries, ultimately advancing patient care.
What are the next steps for AI development in Singapore's healthcare sector?
-The next steps include conducting more research and clinical trials, improving implementation studies to ensure successful adoption, and gaining patient trust to ensure widespread acceptance of AI-driven tools in healthcare.
Outlines
🤖 Singapore's Push for AI in Science and Medicine
Singapore is investing $120 million into AI research, aiming to build a vibrant AI ecosystem and develop bilingual talent proficient in AI and a scientific domain. Professor Joseph S., Dean of Lee Kong Chian School of Medicine, NTU, explains that expertise in AI is crucial, especially in fields like clinical medicine. AI can enhance decision-making in life-and-death scenarios, allowing for more accurate diagnoses and improved treatments. However, those who fail to embrace AI may be left behind or replaced by it.
🧑🔬 Funding AI Research to Improve Medical Outcomes
Professor Joseph emphasizes that the funding will help advance clinical trials, gathering evidence that AI can improve patient outcomes. The money will also support implementation studies, focusing on how AI can streamline healthcare practices. The goal is to ensure both clinics and patients trust the technology, as trust is key for successful adoption in daily medical practices.
🔐 Addressing Ethical Concerns with AI in Medicine
Patients are concerned about AI's accuracy and the security of their personal data. Clinical trials are essential to demonstrate that AI can provide the best treatment outcomes. Data security is another major concern, with fears of data abuse. Healthcare professionals must reassure patients that their data is used securely, gaining their trust in AI-driven practices.
🤝 Building Trust with Patients on AI Usage
According to Professor Joseph, patients are generally receptive to AI when trusted by their doctors. However, for major decisions, such as surgeries performed by AI-powered robots, patients may be more hesitant. Continued research and implementation studies are essential to build acceptance and trust in AI tools across medical procedures.
🌍 AI Adoption and Global Competition
Singapore must keep pace with global developments in AI, especially in healthcare innovations like drug development and diagnostics. Professor Joseph stresses the need for significant investment to remain competitive in the fast-moving global AI landscape, positioning Singapore at the forefront of these advancements.
🏅 Singapore's Strong AI Standing in Science
Singapore has made great strides in AI, surpassing many other countries due to its open system and careful data usage. With significant government investment, Singapore is well-positioned to lead globally in AI-driven healthcare innovations, benefiting industries like diagnostics, pharmaceuticals, and medical devices through improved technology integration.
Mindmap
Keywords
💡AI (Artificial Intelligence)
💡$120 million funding
💡Clinical trials
💡Data security
💡Bilingual talent pool
💡Implementation studies
💡Trust and patient acceptance
💡Global competition in AI
💡Robotic surgery
💡Personal privacy
Highlights
Singapore is investing $120 million to boost AI research, focusing on building a bilingual talent pool proficient in AI and science.
AI has a significant impact on various fields, including entertainment, shopping, and science, with a particular emphasis on clinical medicine.
AI advancements in medicine can help make more accurate diagnoses and improve treatment outcomes for patients.
There is a need for healthcare professionals to understand AI, as it could either benefit them or replace their roles if not properly leveraged.
The funding will support clinical trials and research to provide evidence that AI improves patient outcomes.
Implementation studies will be conducted to explore how AI can streamline daily medical practices and gain trust from patients.
One key concern is whether AI tools can provide accurate recommendations, especially in life-and-death situations.
Data privacy and security are major patient concerns when it comes to AI use in healthcare.
Gaining patient trust is essential for the successful adoption of AI in clinical settings.
Patients are generally receptive to AI when trusted medical professionals advocate its use, but concerns arise with major decisions like surgery.
Singapore aims to stay competitive globally by investing in AI advancements, keeping pace with fast global developments.
Singapore is ahead of many other countries in AI development due to its open data policies and government support.
AI will significantly impact various sectors, including drug development, diagnostics, vaccines, and medical devices.
AI is expected to improve technologies such as CT scans, X-rays, and robotic surgeries, advancing patient treatment.
AI will benefit the healthcare industry as a whole if developed and used responsibly, with public acceptance being key.
Transcripts
in Singapore's next push to be a smart
Nation
$120 million for AI in signs will go
towards building a vibrant research
ecosystem and a bilingual talent pool
proficient in Ai and at least one domain
in science to understand that challenge
we'll speak next to Professor Joseph s
he is Dean of the Le Kong Chen school of
medicine at n he is also co-director
Center of AI in medicine at n uh
professor thank you so much for joining
us today so first of all could you tell
us why it is necessary to be proficient
in Ai and also be an expert in the field
of science well AI penetrate into every
aspects of our life from uh you know
entertainment to shopping but in science
and in my part of the science clinical
medicine it is even more important
because the advancement can go beyond
our knowledge can coped with and uh in
medicine for example where we deal with
life and death situation a lot of
decisions have to made carefully and
therefore with AI we should be able to
make more accurate diagnosis and to
perform better treatment for our
patients however if we don't know how to
leverage this new technology we may not
be benefit from it or we may even be
replaced by technology we are looking at
an investment of $120 million how will
this additional funding support more
research in areas that you are involved
in so in medicine what we need is to
provide more evidence that AI technology
can actually translate into better
outcome for our patients to give better
treatment to our patients so this
funding will be able to help to do
clinical trials so that we can obtain
such evidence besides clinical trials we
should also put the money in into
implementation studies which means that
we want to study how technology can be
applied to our daily practice to
streamline the delivery of service and
that is actually very important because
we cannot just impos on clinics and
patients to use this technology we will
need to gain their trust and support uh
if we want to use it successfully so
when it comes to using AI um and also
you were talking about expanding our
clinical trials initiatives there
naturally there are concerns about its
risks and ethics but patients would want
to know how will the use of AI in
science and medicine benefit them yeah I
think from the patients perspective two
major uh concern is number one whether
AI is actually accurate whether the
recommendation that they give give them
the best benefit of the treatment so
that part can be answered by clinical
trials the other part that patients
usually are concern is that when their
data when their personal privacy uh it's
being exposed to AI whether this data
being used securely whether um people
will not be able to abuse the data so
data security is another major concern
so for us who are going to use AI in
clinical practice we will have to you
know exercise um our discretion to use
AI in the appropriate way and to
reassure our patient that their data
will not be leaked it is really about
gaining the support and Trust in the
patients uh have they been generally
receptive to using AI tools though I
mean or do you think more needs to be
done to encourage them to to be involved
in AI Tools in general I think our
patients are quite uh receptive to the
idea especially if they're doctors and
nurses are trusting the use of AI
however when it comes to Major decision
for example whether or not they need a
major surgery or whether the robots with
AI is doing the surgery is instead of
their human doctor is doing it yeah then
there will be more concern about it so I
think we will still continue to do more
research and also to do more
implementation study as I said to gain
the acceptance and Trust of our patients
how will boosting AI adoption and
development in sence uh Fields stad
Singapore amidst the global competition
well the whole world is moving really
fast in this development uh from drug
development vaccines new Diagnostics new
CT and so on so we should really be uh
putting a lot of efforts and resources
to invest onto this so that Singapore
can keep a breast to the the frontiers
of of this new advancement where does
Singapore globally when it comes to AI
in science Fields Prof I would say that
Singapore is actually doing very well uh
we are ahead of many other country
because we have a very open system uh
the data is uh being used very carefully
and uh the government has put in quite
significant resources to develop this so
we are in a very good position to
advance further and even lead the world
in this area looking at this new wave of
AI in science and Healthcare how do you
think is going to change or help the
industry as a whole well the industry
obviously will also benefit from it if
AI is developed in the right way and
being used appropriately and accepted by
the public from the diagnostic company
to pharmaceutical company or even
company that make machines such as uh
x-rays CT scaned or robots uh a lot of
AI can be applied into these devices to
advance the treatment for our patients
Professor s we appreciate your insights
thank you so much for speaking with us
tonight that was Professor Joseph s from
the Lee Kong Chan school of medicine at
NTU
浏览更多相关视频
Navigating the Clinical AI landscape
4 Ways Artificial Intelligence is Transforming Healthcare
China's AI Hospitals Are More Advanced Than You Think
Artificial Intelligence in Gastroenterology (AI for GI)
The future of AI in medicine | Conor Judge | TEDxGalway
How AI is accelerating drug discovery - Nature's Building Blocks | BBC StoryWorks
5.0 / 5 (0 votes)